Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology

Autor: Steven Coutre, Alexander E. Perl, Richard Stone, Vijaya Raj Bhatt, Deniz Peker, Ndiya Ogba, Keith W. Pratz, Frederick R. Appelbaum, Martin S. Tallman, Michael Gary Martin, Thomas W. LeBlanc, Alice S. Mims, Dale L. Bixby, Aric C. Hall, Paul J. Shami, Jeffrey E. Lancet, Marcos de Lima, Stephen A. Strickland, Thomas Prebet, Melanie Fiorella, Meagan A. Jacoby, Lydia J. Hammond, Margaret R. O'Donnell, Guido Marcucci, Jessica K. Altman, Rebecca L. Olin, Daniel A. Pollyea, Gabriel N. Mannis, Matthew J. Wieduwilt, Farhad Ravandi, Eunice S. Wang, Kristina M. Gregory, James M. Foran, Amir T. Fathi
Rok vydání: 2019
Předmět:
Zdroj: Journal of the National Comprehensive Cancer Network. 17:721-749
ISSN: 1540-1413
1540-1405
DOI: 10.6004/jnccn.2019.0028
Popis: Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age
Databáze: OpenAIRE